About Sparrow Acoustics
Sparrow BioAcoustics is a Canadian medical technology company specializing in cardiac and pulmonary bioacoustic analysis. The company's flagship product, Stethophone Pro, is a regulated Software as a Medical Device platform that transforms smartphones into professional-grade cardiac assessment tools capable of detecting valvular heart disease, arrhythmias, and structural heart conditions. The platform employs proprietary AI phonoscopy technology trained on millions of heart cycles to analyze cardiac sounds and generate structured clinical signals. Stethophone Pro is designed for upstream detection in routine clinical workflows including primary care, urgent care, pre-operative assessments, and hospital intake. The system performs deep heart sound characterization through advanced signal processing, temporal alignment, and clinical interpretation to identify murmurs and other cardiac abnormalities. Stethophone Pro is FDA-cleared and regulated as a medical device in the USA, Canada, and Ukraine. The platform integrates into existing clinical smartphone programs without requiring specialized hardware, enabling scalable cardiovascular detection infrastructure across health systems. Clinical validation studies demonstrate sensitivity and specificity exceeding 93% for murmur detection and 97% accuracy for cardiac cycle analysis. The company serves health systems, cardiology programs, and structural heart teams seeking to improve upstream patient identification, referral precision, and care pathway efficiency.
Mission & Story
Mission
To help millions of people get better, faster care by making proactive cardiac health monitoring an easier part of everyone's life
Founding Story
Co-founder Nadia Ivanova was inspired to create Sparrow after facing a disease that could have been prevented if detected early, dreaming of giving people a way to check their health at home anytime. The founding team combined cardiology expertise, medical acoustics specialization, and SaaS product development experience to build accessible cardiac diagnostic technology.
Clinical Focus
Medical conditions and clinical areas addressed by Sparrow Acoustics.
Who It Serves
Milestones & Awards
Recent Milestones
Gold Winner 2026 NY Product Design Awards for Smartphone-Based AI Cardiac Diagnostics. Winner 2025 CIO Awards Canada AI Implementor of the Year. 2025 International Design Awards winner. Member of American Heart Association Innovators' Network (2025). Published clinical validation study in 2025.
Awards & Recognition
2026 NY Product Design Awards Gold Winner, 2026 Global Recognition Award, 2026 Muse Design Awards, 2025 International Design Awards, 2025 CIO Awards Canada AI Implementor of the Year Winner, American Heart Association Innovators' Network Member
Key Partnerships
Social & Media
Latest Updates
Company Details
- Headquarters
- Canada
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.